ArticleBMC ophthalmology2026
Evaluation of stability and visual quality in Chinese myopic eyes 2 years following FS-LASIK combined with prophylactic corneal crosslinking.
Article in BMC ophthalmology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundTo assess corneal stability of femtosecond laser-assisted in situ keratomileusis combined with prophylactic corneal crosslinking (FS-LASIK Xtra) for myopic correction and compare the visual quality to FS-LASIK at 2 years postoperative.
methodsData of 40 patients (80 eyes) receiving FS-LASIK Xtra were collected in the longitudinal study. They were identified as “borderline” with the risk factors including younger in age, thinner corneal thickness, irregular cornea, or weak corneal biomechanics before surgery. 20 patients (40 eyes) of them were recalled for a comprehensive visit at 2 years postoperative, along with a matched group of 27 patients (54 eyes) without risk factors and receiving FS-LASIK alone during the same period. Confounders including age, gender, and baseline refractive parameters were controlled. Refractive status, corneal morphology and biomechanics, epithelial thickness (ET), subjective and objective visual quality, and tear film stability were examined. Generalized linear mixed models were constructed for comparative and correlative analyses.
resultsSpherical equivalent (SE), thinnest corneal thickness, integrated radius, central ET changed significantly from 6 months to 2 years after FS-LASIK Xtra (all P < 0.050). There was no statistical difference in SE, biomechanics, higher-order aberrations (HOAs), contrast sensitivity, tear break-up time, and total score of Quality of Vision questionnaire between two surgical groups at 2 years postoperative (all P > 0.050). FS-LASIK Xtra group had greater postoperative objective scattering index (OSI) and corneal densitometry than FS-LASIK group (all P < 0.050). Epithelial remodeling was lower after FS-LASIK Xtra though significance was only observed in pericentral zone (P < 0.050), and its correlation with HOAs was evident in coma (P < 0.050).
conclusionsFS-LASIK Xtra demonstrated its potential in borderline cases for effective myopic correction, along with improvements in corneal morphology and biomechanics during this 2-year visit. However, the additional crosslinking seemed to increase light scatter indicated by higher corneal densitometry and OSI, though patients reported comparable subjective visual outcomes to those of FS-LASIK alone. And postoperative epithelial remodeling still requires long-term monitoring.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.